Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from United Therapeutics

Lancet Results Show Ralinepag Cut Clinical Worsening by 55 Percent in Pulmonary Arterial Hypertension

Published Lancet results show ralinepag reduced clinical worsening in PAH by 55%. The drug is still investigational and not FDA-approved.

Medical Daily

These 3 Stocks Lowered Their Share Counts Drastically in Q1

Pinterest, Southwest Airlines, and United Therapeutics each executed significant share repurchases in Q1 2026, reducing their outstanding share counts by 16%, 5%, and 3.2%, respectively.

MarketBeat

First clinical trial testing pig kidney transplants in people launches in US

The small trial is the latest step in the quest for animal-to-human transplants.

Euronews

From analysis to the latest developments in health,
read the most diverse news in one place.

Groundbreaking pig organ transplant trial gets underway

It’s the latest step in the quest for animal-to-human transplants

The Independent UK

This United Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Benzinga

Why Is United Therapeutics Stock Rallying On Tuesday?

United Therapeutics Corporation (NASDAQ:UTHR) released data on Tuesday from its TETON-2 study evaluating the use of nebulized Tyvaso (treprostinil) Inhalation Solution for idiopathic pulmonary fibrosis (IPF).

Benzinga

United Therapeutics Stock Slides On Q2 Earnings: The Details

United Therapeutics Corp (NASDAQ:UTHR) reported second-quarter financial results before the market open on Wednesday. Here’s a rundown of the report.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

The Top 3 Stock Picks at the World’s Greatest Hedge Fund

See which three stocks the world's most successful hedge fund, which generated returns of +30% for decades, had the biggest stakes in at the end of 2024.

MarketBeat

New Hampshire man is 2nd person known to be living with a pig kidney

A New Hampshire man has become the second person known to be living with a pig kidney

The Independent UK

A US Farm Breeds Pigs For Human Kidney Transplants

On a farm in the southern US state of Virginia, David Ayares and his research teams are breeding genetically modified pigs to transplant their organs into human patients.

International Business Times

Pig transplant research yields a surprise: Bacon safe for some people allergic to red meat

Some people develop a weird allergy to red meat after being bitten by a lone star tick yet find they can still eat pork from a surprising source - certain pigs originally bred for human organ transplants

The Independent UK

Meet the world’s cleanest pigs – genetically modified to grow kidneys and hearts for humans

The pigs breathe air and drink water that’s better filtered against contaminants than what’s required for people

The Independent UK

Chart of the Day: United Therapeutics - Drugs for Chronic Illnesses

The Chart of the Day belongs to the pharmaceutical company United Therapeutics (UTHR) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the Flipchart...

Barchart

How to Enhance Your Own Strategies with POWR Ratings

Wall Street is never lacking in strategy or trading ideas. In investing, if you can combine two or more strategies that align around a particular investing idea, you can enhance your likelihood of success. This idea combines our POWR Ratings with a strategy that is currently making the rounds on…

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.